Viewing Opinion | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

2017-05-17

Opinion for Abbott Labs (ABT-N)

Signal Price Bias Subject Owned
TOP PICK $43.080 UNKNOWN US EQUITIES Yes

Healthcare, as a sector, is neutral to tilting positively. Within that though, there are some industry groups that he likes, and some he doesn’t like. This one is in the subsector of medical devices, and is a great diversified player in that space. Their acquisition of St. Jude broadens their business and cardiovascular. Dividend yield of 2.4%. (Analysts’ price target is $48.)

Cameron Hurst
Chief Investment Officer, Equium Capital Management

No Comments.


You must be logged in to comment.